Meag Munich Ergo’s Amgen AMGN Stock Holding History

Meag Munich Ergo’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$12.6M	Buy	45,160 +3,922	+10%	+$1.11M	0.36%	65
2025 Q1	$12.8M	Buy	41,238 +40,512	+5,580%	+$12M	0.38%	61
2024 Q4	$188K	Hold	726	–	–	0.01%	171
2024 Q3	$234K	Buy	+726	New	+$237K	0.01%	160
2024 Q2	–	Sell	-713	Closed	-$203K	–	183
2024 Q1	$203K	Hold	713	–	–	0.01%	150
2023 Q4	$205K	Sell	713 -18,300	-96%	-$4.99M	0.01%	144
2023 Q3	$5.11M	Buy	19,013 +9,264	+95%	+$2.31M	0.22%	86
2023 Q2	$2.16M	Sell	9,749 -420	-4%	-$97.5K	0.09%	109
2023 Q1	$2.46M	Sell	10,169 -13,175	-56%	-$3.23M	0.12%	98
2022 Q4	$6.13M	Sell	23,344 -2,236	-9%	-$599K	0.33%	60
2022 Q3	$5.77M	Buy	25,580 +18,874	+281%	+$4.57M	0.35%	59
2022 Q2	$1.63M	Buy	6,706 +693	+12%	+$170K	0.1%	119
2022 Q1	$1.47M	Buy	6,013 +4,513	+301%	+$1.04M	0.11%	116
2021 Q4	$341K	Sell	1,500 -15,946	-91%	-$3.37M	0.02%	155
2021 Q3	$3.71M	Hold	17,446	–	–	0.65%	55
2021 Q2	$4.25M	Sell	17,446 -24,770	-59%	-$6.09M	0.41%	75
2021 Q1	$10.5M	Buy	42,216 +17,834	+73%	+$4.26M	1.06%	18
2020 Q4	$5.54M	Hold	24,382	–	–	1.27%	12
2020 Q3	$6.2M	Sell	24,382 -1,487	-6%	-$368K	1.15%	20
2020 Q2	$6.1M	Sell	25,869 -10,668	-29%	-$2.43M	1.15%	19
2020 Q1	$7.41M	Sell	36,537 -4,239	-10%	-$926K	1.76%	13
2019 Q4	$9.8M	Sell	40,776 -15,878	-28%	-$3.5M	1.05%	20
2019 Q3	$11M	Buy	56,654 +22,113	+64%	+$4.24M	0.57%	40
2019 Q2	$6.37M	Buy	34,541 +5,893	+21%	+$1.06M	0.5%	48
2019 Q1	$5.37M	Sell	28,648 -37	-0.1%	-$7.07K	0.44%	52
2018 Q4	$5.47M	Sell	28,685 -15,710	-35%	-$3.06M	0.67%	38
2018 Q3	$9.22M	Buy	44,395 +20,395	+85%	+$4.02M	0.55%	49
2018 Q2	$4.44M	Sell	24,000 -62,730	-72%	-$11.1M	0.28%	119
2018 Q1	$14.7M	Buy	86,730 +14,419	+20%	+$2.65M	0.6%	38
2017 Q4	$12.7M	Buy	72,311 +21,798	+43%	+$3.86M	0.49%	54
2017 Q3	$9.4M	Buy	50,513 +24,983	+98%	+$4.43M	0.38%	90
2017 Q2	$4.4M	Sell	25,530 -24,852	-49%	-$4.04M	0.2%	150
2017 Q1	$8.25M	Sell	50,382 -28,686	-36%	-$4.77M	0.33%	110
2016 Q4	$11.7M	Sell	79,068 -12,896	-14%	-$1.94M	0.55%	51
2016 Q3	$15.2M	Sell	91,964 -10,547	-10%	-$1.78M	0.75%	43
2016 Q2	$15.6M	Buy	102,511 +51,025	+99%	+$7.93M	1.41%	21
2016 Q1	$7.74M	Buy	51,486 +44,486	+636%	+$6.61M	0.4%	87
2015 Q4	$1.15M	Sell	7,000 -128,770	-95%	-$20.2M	0.06%	184
2015 Q3	$18.6M	Buy	135,770 +12,937	+11%	+$2.04M	1%	25
2015 Q2	$18.8M	Buy	122,833 +25,103	+26%	+$4.02M	0.97%	27
2015 Q1	$15.8M	Buy	97,730 +34,482	+55%	+$5.43M	0.76%	39
2014 Q4	$10.2M	Sell	63,248 -84,433	-57%	-$13.2M	0.46%	74
2014 Q3	$20.7M	Buy	147,681 +17,658	+14%	+$2.31M	0.96%	29
2014 Q2	$15.4M	Buy	130,023 +62,454	+92%	+$7.23M	0.67%	45
2014 Q1	$8.34M	Sell	67,569 -8,545	-11%	-$1.04M	0.62%	54
2013 Q4	$8.78M	Buy	76,114 +73,814	+3,209%	+$8.4M	0.52%	63
2013 Q3	$258K	Sell	2,300 -17,836	-89%	-$1.93M	0.02%	201
2013 Q2	$2.01M	Buy	+20,136	New	+$2.09M	0.15%	134

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Meag Munich Ergo's AMGN Position: Q2 2025 in Review

Meag Munich Ergo increased its Amgen (AMGN) stake by 9.5% in Q2 2025, buying an estimated $1.11M and bringing the position to 45,160 shares worth $12.6M. The position accounts for 0.36% of the portfolio, ranked #65.

Meag Munich Ergo first reported a position in AMGN in Q2 2013 and has held it in 48 quarters since. The position peaked at $20.7M in Q3 2014. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

Meag Munich Ergo held 45,160 shares of Amgen worth $12.6M as of Q2 2025.
Meag Munich Ergo bought 3,922 Amgen shares in Q2 2025, an estimated $1.11M.
Amgen made up 0.36% of Meag Munich Ergo's portfolio in Q2 2025, its #65 holding.
Meag Munich Ergo first reported a position in Amgen in Q2 2013 and has held it in 48 quarters since.
Meag Munich Ergo's Amgen position peaked at $20.7M in Q3 2014.
2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Meag Munich Ergo's 13F filing for Q2 2025, filed 16 Jul 2025.